Xyloct-Solofarm, spray 35 µg/dose 15 ml
€4.58 €4.07
Acute respiratory diseases with rhinitis (runny nose) acute allergic rhinitis pollinosis sinusitis eustachianitis otitis media (to reduce nasopharyngeal mucosal edema).
Patient preparation for diagnostic manipulations in the nasal passages.
Indications
Acute respiratory diseases with symptoms of rhinitis (runny nose), acute allergic rhinitis, hay fever, sinusitis, eustachitis, otitis media (to reduce swelling of the nasopharyngeal mucosa).
Preparing the patient for diagnostic manipulations in the nasal passages.
Special instructions
Avoid getting the drug into your eyes.
To avoid the spread of infection, it is necessary to use the drug individually.
Do not exceed the recommended doses and use the drug for a long time (more than 7 days). Long-term use of the drug can cause a “ricochet” effect (medicinal rhinitis); the risk of reactive hyperemia and atrophy of the nasal mucosa increases.
Since the drug contains benzalkonium chloride as a preservative, especially with long-term use (more than 7 days), swelling of the nasal mucosa may develop. If there is a suspicion of such a reaction (nasal congestion), it is necessary, if possible, to use a medicine that does not contain preservatives. If such drugs are not available, another dosage form must be used.
Impact on the ability to drive vehicles. Wed and fur.:
Xylometazoline may affect the ability to operate vehicles or operate equipment.
When treating with the drug, care must be taken when driving vehicles and engaging in other potentially hazardous activities that require increased concentration and speed of psychomotor actions.
Active ingredient
Xylometazoline
Composition
Composition of the drug for 1 dose
1 dose of the drug contains:
Active substance:
Xylometazoline hydrochloride – 35 mcg,
Excipients:
Benzalkonium chloride – 7.0 mcg,
Disodium edetate (trilon B) – 35.0 mcg,
Sodium hydrogen phosphate dihydrate – 140.0 mcg,
Sodium dihydrogen phosphate dihydrate – 140.0 mcg,
Sodium chloride – 518.0 mcg,
Water for injection – 69.4 mg.
Pregnancy
The use of the drug during pregnancy is contraindicated.
It is possible to use the drug during breastfeeding as prescribed by the attending physician if the expected therapeutic effect in the mother exceeds the risk of possible side effects in the child.
Contraindications
– Hypersensitivity to the components of the drug;
– arterial hypertension;
– tachycardia;
– severe atherosclerosis;
– glaucoma;
– atrophic rhinitis;
– thyrotoxicosis;
– surgical interventions on the meninges (history);
– conditions after transsphenoidal hypophysectomy;
– children under 2 years of age – for SOLOXYLOMETAZOLINE nasal spray dosed 35 mcg/dose;
– children under 6 years of age – for SOLOxylometazoline nasal spray dosed 140 mcg/dose;
– pregnancy.
Do not use during therapy with monoamine oxidase inhibitors and tricyclic antidepressants (including the period of 14 days after their discontinuation).
With caution:
Diabetes mellitus prostatic hyperplasia coronary heart disease (angina) pheochromocytoma hyperthyroidism lactation period; with increased sensitivity to adrenergic drugs accompanied by insomnia, dizziness, arrhythmia, tremor, and increased blood pressure.
Side Effects
With frequent and/or prolonged use – irritation and/or dryness of the mucous membrane of the nasopharynx, burning, tingling, sneezing, hypersecretion of the mucous membrane of the nasopharynx, hypersensitivity reactions, swelling of the mucous membrane of the nasal cavity, palpitations, tachycardia arrhythmia, increased blood pressure, headache, nausea, vomiting, insomnia, blurred vision, depression (with long-term use of high doses).
If any of the side effects indicated in the instructions get worse or you notice any other side effects not listed in the instructions, tell your doctor.
Interaction
Xylometazoline should not be used in patients receiving therapy with monoamine oxidase inhibitors and tricyclic antidepressants (including the period of 14 days after their discontinuation) due to the possibility of increasing blood pressure.
Overdose
Symptoms: increased side effects (dose-dependent), decreased body temperature, confusion. If accidentally ingested, the drug may cause: severe dizziness, increased sweating, headache, bradycardia, increased blood pressure, respiratory depression, coma and convulsions. After an increase in blood pressure, a sharp decrease may be observed.
Treatment: symptomatic.
Storage conditions
At a temperature not exceeding 25 °C.
Keep out of the reach of children.
Shelf life
2 years.
Do not use after the expiration date.
Manufacturer
Grotex LLC, Russia
Shelf life | 2 years. Do not use after the expiration date. |
---|---|
Conditions of storage | At a temperature not exceeding 25 ° C. Store out of the reach of children. |
Manufacturer | Grotex Ltd, Russia |
Medication form | dosed nasal spray |
Brand | Grotex Ltd |
Other forms…
Related products
Buy Xyloct-Solofarm, spray 35 µg/dose 15 ml with delivery to USA, UK, Europe and over 120 other countries.